Corona Remedies IPO Details
| IPO Open Date | December 8, 2025 |
| IPO Close Date | December 10, 2025 |
| Face Value | ₹10 Per Equity Share |
| IPO Price Band | ₹1008 to ₹1062 Per Share |
| Issue Size | Approx ₹655.37 Crores |
| Offer for Sale: | Approx 61,71,101 Equity Shares |
| Issue Type | Book Built Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus |  |
| RHP Draft Prospectus | |
Corona Remedies IPO Review & Key Points
- Review:
Corona Remedies IPO Market Lot
The Corona Remedies IPO minimum market lot is 14 shares with ₹14,868 application amount. The retail investors can apply up-to 13 lots with 182 shares of ₹1,93,284 amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 14 | ₹14,868 |
| Retail Maximum | 13 | 182 | ₹1,93,284 |
| S-HNI Minimum | 14 | 196 | ₹2,08,152 |
| S-HNI Maximum | 67 | 938 | ₹9,96,156 |
| B-HNI Minimum | 68 | 952 | ₹10,11,024 |
IPO Reservation
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | – Shares | 50% |
| NII Shares Offered | – Shares | 15% |
| Retail Shares Offered | – Shares | 35% |
Corona Remedies IPO Anchor Investors
| Anchor Bidding Date | December 5, 2025 |
| Anchor Investors List | |
| Shares Offered | [.] Shares |
| Anchor Size | [.] Cr. |
| lock-in period end date 50% shares (30 Days) | January 10, 2026 |
| lock-in period end date 50% shares (90 Days) | March 11, 2026 |
Corona Remedies IPO Dates
The Corona Remedies IPO date is December 8 and the close date is December 10. The Corona Remedies IPO allotment will be finalized on December 11 and the IPO listing on December 15.
| IPO Open Date: | December 8, 2025 |
| IPO Close Date: | December 10, 2025 |
| Basis of Allotment: | December 11, 2025 |
| Refunds: | December 12, 2025 |
| Credit to Demat Account: | December 12, 2025 |
| IPO Listing Date: | December 15, 2025 |
| IPO Bidding Cut-off Time: | December 10, 2025 – 5 PM |
Promoters and Holding Pattern
The promoters of the company are Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta.
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 6,11,60,088 | 72.50% |
| Promoter Holding Post Issue | 6,11,60,088 | -% |
Objects of the Issue & Utilisation of proceeds
- NA
About Corona Remedies IPO
Founded in August 2004, Corona Remedies Limited is one of the leading pharmaceutical companies that is involved in manufacturing and selling products for women’s health, heart care, pain relief, urology, and other treatments. As per the report, among 30 others, Corona Remedies is the 2nd largest company in the Indian Pharmaceutical Market (“IPM”). Moreover, the company comprises a total of 88 R&D employees as of December 31, 2024.
The company offers 67 brands across various therapeutic areas, including women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory) as of December 2024. The company offers a pan-India presence with 2,598 medical representatives in 22 states. It comprises 2 manufacturing facilities located in the state of Gujarat.
Corona Remedies IPO Company Financial Report
Amount ₹ in Crores
| Period Ended | Revenue | Expense | PAT | Assets |
| 2023 | ₹891.10 | ₹756.07 | ₹84.93 | ₹595.02 |
| 2024 | ₹1,020.93 | ₹859.74 | ₹90.50 | ₹830.58 |
| 2025 | ₹1,202.35 | ₹956.44 | ₹149.43 | ₹929.86 |
| June 2025 | ₹348.56 | ₹276.76 | ₹46.20 | ₹1,012.38 |
Corona Remedies IPO Valuation – FY2025
Check Corona Remedies IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 27.50% |
| ROCE: | 41.32% |
| EBITDA Margin: | 20.55% |
| PAT Margin: | 12.49% |
| Debt to equity ratio: | – |
| Earning Per Share (EPS): | ₹24.43 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 24.65% |
| Net Asset Value (NAV): | ₹99.14 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Abbott India Limited | 665.62 | 54.28 | 33.41% | 1,992.14 | 6,409.15 Cr. |
| Alkem Laboratories Limited | 181.11 | 32.96 | 18.07% | 1,002.37 | 12,964.52 Cr. |
| Eris Lifesciences Limited | 25.85 | 47.99 | 12.21% | 209.73 | 2,893.64 Cr. |
| GlaxoSmithKline Pharmaceuticals Limited | 54.76 | 83.53 | 47.54% | 115.19 | 3,749.21 Cr. |
| J.B. Chemicals & Pharmaceuticals Limited | 42.45 | 47.21 | 19.21% | 220.88 | 3,917.99 Cr. |
| Mankind Pharma Limited | 49.28 | 54.17 | 13.89% | 352.51 | 12,207.44 Cr. |
| Pfizer Limited | 167.79 | 34.56 | 18.20% | 921.88 | 2,281.35 Cr. |
| Sanofi India Limited | 179.46 | 23.76 | 48.05% | 373.68 | 2,013.20 Cr. |
| Torrent Pharmaceuticals Limited | 56.47 | 66.51 | 25.18% | 224.28 | 11,516.09 Cr. |
IPO Lead Managers aka Merchant Bankers
- JM Financial Ltd.
- IIFL Capital Services Ltd.
- Kotak Mahindra Capital Co. Ltd.
Company Address
Corona Remedies Ltd.
CORONA House, C – Mondeal Business Park
Near Gurudwara S. G. Highway
Thaltej
Ahmedabad, Gujarat, 380059
Phone: +91 79 4023 3000
Email: [email protected]
Website: https://www.coronaremedies.com/
IPO Registrar
Bigshare Services Pvt. Ltd.
Phone: +91-22-6263 8200
Email: [email protected]
Website: https://ipo.bigshareonline.com/IPO_Status.html
Corona Remedies IPO FAQs
What is Corona Remedies IPO?
When Corona Remedies IPO will open for subscription?
What is Corona Remedies IPO Investors Portion?
How to Apply the Corona Remedies IPO?
What is Corona Remedies IPO Issue Size?
What is Corona Remedies IPO Price Band?
What is Corona Remedies IPO Lot Size?
What is the Corona Remedies IPO Allotment Date?
What is the Corona Remedies IPO Listing Date?
Note: The Corona Remedies IPO price band and date are officially announced. The (Corona Remedies IPO grey market premium) will be added to the IPO GMP page as it will start).
One Response
QIB…50%
HNI…15%
Retail…35%